Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: Results from the open-label, randomised controlled ORAL Surveillance trial

  1. Curtis, J.R.
  2. Yamaoka, K.
  3. Chen, Y.-H.
  4. Bhatt, D.L.
  5. Gunay, L.M.
  6. Sugiyama, N.
  7. Connell, C.A.
  8. Wang, C.
  9. Wu, J.
  10. Menon, S.
  11. Vranic, I.
  12. Gómez-Reino, J.J.
Revista:
Annals of the Rheumatic Diseases

ISSN: 1468-2060,  0003-4967

Ano de publicación: 2023

Volume: 82

Número: 3

Páxinas: 331-343

Tipo: Artigo

DOI: 10.1136/ARD-2022-222543 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus